About Qualigen Therapeutics Inc
Ticker
info
QLGN
Trading on
info
NASDAQ
ISIN
info
US74754R1032
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Kevin A. Richardson II
Headquarters
info
5857 Owens Avenue, Carlsbad, CA, United States, 92008
Employees
info
0
Website
info
https://qlgntx.com
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1 clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS, for the treatment of advanced solid tumors, which is in a preclinical stage. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Metrics
BasicAdvanced
Market cap
info
$3.6M
P/E ratio
info
-
EPS
info
-$1.48
Dividend Yield
info
0.00%
Beta
info
0.03
Forward P/E ratio
info
0
EBIDTA
info
$-6.9M
Ex dividend date
info
-
Price & volume
Market cap
info
$3.6M
Average daily volume
info
2.5M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0.39
Price to book
info
0.41
Earnings
EPS
info
-$1.48
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-6.9M
Revenues (TTM)
info
$5M
Revenues per share (TTM)
info
$1.03
Technicals
Beta
info
0.03
52-week High
info
$11.50
52-week Low
info
$2.00
50-day moving average
info
$3.46
200-day moving average
info
$3.94
Short ratio
info
1.29
Short %
info
1.53%
Management effectiveness
ROE (TTM)
info
-841.66%
ROA (TTM)
info
-211.25%
Profit margin
info
0.00%
Gross profit margin
info
$0.3M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
13.70%
Share stats
Outstanding Shares
info
1.6M
Float
info
1.6M
Insiders %
info
1.70%
Institutions %
info
0.09%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

info
$5.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$1,045.22
-
-
Q2 • 15Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-0.9M
-∞%
Q1 • 25
$-2.6M
0.00%
Q2 • 25
NaN%
209.20%
0.00%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$4.7M
$2M
42.84%
Q1 • 25
$2.8M
$2.8M
98.84%
Q2 • 25
-39.24%
40.20%
130.74%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-2.3M
$-0.3M
$4.1M
$-2.3M
Q1 • 25
$-1.6M
-
$0.8M
$-1.6M
Q2 • 25
-29.97%
-
-81.54%
-29.97%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Qualigen Therapeutics Inc share?
Collapse

Qualigen Therapeutics Inc shares are currently traded for undefined per share.

How many shares does Qualigen Therapeutics Inc have?
Collapse

Qualigen Therapeutics Inc currently has 1.6M shares.

Does Qualigen Therapeutics Inc pay dividends?
Collapse

No, Qualigen Therapeutics Inc doesn't pay dividends.

What is Qualigen Therapeutics Inc 52 week high?
Collapse

Qualigen Therapeutics Inc 52 week high is $11.50.

What is Qualigen Therapeutics Inc 52 week low?
Collapse

Qualigen Therapeutics Inc 52 week low is $2.00.

What is the 200-day moving average of Qualigen Therapeutics Inc?
Collapse

Qualigen Therapeutics Inc 200-day moving average is $3.94.

Who is Qualigen Therapeutics Inc CEO?
Collapse

The CEO of Qualigen Therapeutics Inc is Kevin A. Richardson II.

How many employees Qualigen Therapeutics Inc has?
Collapse

Qualigen Therapeutics Inc has 0 employees.

What is the market cap of Qualigen Therapeutics Inc?
Collapse

The market cap of Qualigen Therapeutics Inc is $3.6M.

What is the P/E of Qualigen Therapeutics Inc?
Collapse

The current P/E of Qualigen Therapeutics Inc is null.

What is the EPS of Qualigen Therapeutics Inc?
Collapse

The EPS of Qualigen Therapeutics Inc is -$1.48.

What is the PEG Ratio of Qualigen Therapeutics Inc?
Collapse

The PEG Ratio of Qualigen Therapeutics Inc is null.

What do analysts say about Qualigen Therapeutics Inc?
Collapse

According to the analysts Qualigen Therapeutics Inc is considered a buy.